Antigens, Tumor-Associated, Carbohydrate
"Antigens, Tumor-Associated, Carbohydrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
| Descriptor ID |
D015295
|
| MeSH Number(s) |
D23.050.285.050 D23.050.550.325 D23.101.140.075
|
| Concept/Terms |
Antigens, Tumor-Associated, Carbohydrate- Antigens, Tumor-Associated, Carbohydrate
- Carbohydrate Antigens, Tumor-Associated
- Antigens, Tumor-Associated Carbohydrate
- Carbohydrate Antigens, Tumor Associated
- Tumor-Associated Carbohydrate Antigens
- Tumor Associated Carbohydrate Antigens
- CA Antigen
- Antigen, CA
- Epitectin
- CA(Oxford) Antigen
- Cancer-Associated Carbohydrate Antigens
- Antigens, Cancer-Associated Carbohydrate
- Cancer Associated Carbohydrate Antigens
- Carbohydrate Antigens, Cancer-Associated
- Antigen, Carcinoma-Associated
- Antigen, Carcinoma Associated
- Carcinoma-Associated Antigen
- Carcinoma Associated Antigen
- Antigens, Carbohydrate, Tumor-Associated
- CA Antigens
- Antigens, CA
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Tumor-Associated, Carbohydrate".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Tumor-Associated, Carbohydrate".
This graph shows the total number of publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in this website by year, and whether "Antigens, Tumor-Associated, Carbohydrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in Profiles.
-
Whalen GF, Sullivan M, Piperdi B, Wasseff W, Galili U. Cancer immunotherapy by intratumoral injection of a-gal glycolipids. Anticancer Res. 2012 Sep; 32(9):3861-8.
-
Wu WC, Lai CC, Liu JH, Singh T, Li LM, Peumans WJ, Van Damme EJ, Wu AM. Differential binding to glycotopes among the layers of three mammalian retinal neurons by man-containing N-linked glycan, T(alpha) (Galbeta1-3GalNAcalpha1-), Tn (GalNAcalpha1-Ser/Thr) and I (beta)/II (beta) (Galbeta1-3/4GlcNAcbeta-) reactive lectins. Neurochem Res. 2006 May; 31(5):619-28.
-
Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Cancer Res. 1993 Jun 15; 53(12):2803-9.
-
Gallion HH, Hunter JE, van Nagell JR, Averette HE, Cain JM, Copeland LJ, Higgins RV, Husseinzadeh N, Nahhas WA, Partridge EE, et al. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer. Gynecol Oncol. 1992 Jul; 46(1):29-32.
-
Hnatowich DJ, Griffin TW, Kosciuczyk C, Rusckowski M, Childs RL, Mattis JA, Shealy D, Doherty PW. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients. J Nucl Med. 1985 Aug; 26(8):849-58.